Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences

Rhea-AI Summary

Lexicon Pharmaceuticals (Nasdaq: LXRX) will participate in three investor events in March 2026. Management will speak at a Leerink Partners fireside chat on March 11, 2026 at 10:00 a.m. and hold 1x1 meetings at Jefferies Biotech on the Beach and Barclays Global Healthcare, March 10–12.

According to the company, a live recording and replay of the Leerink fireside chat will be available via the company Events page.

Key Figures

Leerink fireside chat time: 10:00 a.m. Jefferies summit dates: March 10–11 Barclays conference dates: March 10–12 +1 more

4 metrics

Leerink fireside chat time 10:00 a.m. Scheduled time on March 11, 2026

Jefferies summit dates March 10–11 Jefferies Biotech on the Beach Summit participation window

Barclays conference dates March 10–12 Barclays 28th Global Healthcare Conference participation window

Barclays conference number 28th Edition of Barclays Global Healthcare Conference

Market Reality Check

Price: $1.61 Vol: Volume 2,736,438 is 9% ab...

normal vol

$1.61 Last Close

Volume Volume 2,736,438 is 9% above 20-day average, indicating elevated interest. normal

Technical Price $1.56 is trading above 200-day MA at $1.19, reflecting a stronger intermediate trend.

Peers on Argus

LXRX gained 6.12% with modestly above-average volume while sector peers were mix...

2 Down

LXRX gained 6.12% with modestly above-average volume while sector peers were mixed: AURA +7.14%, INBX +6.91%, SLDB +2.82%, ATXS +0.8%, FULC -4.41%. The momentum scanner flagged INBX and ADCT moving down about 0.4%, so broader biotech signals were not uniformly in LXRX’s direction.

Common Catalyst At least one peer (FULC) also announced participation in the Leerink Partners Global Healthcare Conference, suggesting a shared investor-relations focus rather than a fundamental catalyst.

Historical Context

5 past events · Latest: Feb 26 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 26	Earnings date notice	Neutral	+0.0%	Announced timing of Q4 2025 results and conference call.
Feb 06	Offering closing	Negative	-2.4%	Closed $94.6M public offering and concurrent private placement.
Jan 30	Offering pricing	Negative	-19.4%	Priced large equity offering and private placement for corporate needs.
Jan 29	Proposed offering	Negative	-19.4%	Proposed underwritten public offering and concurrent private placement.
Jan 23	Corporate milestone	Positive	-3.4%	Announced Nasdaq closing-bell event to mark 30th anniversary.

Pattern Detected

Recent financing announcements correlated with notable share price declines, while neutral corporate events (earnings date, bell-ringing) saw flat to mildly negative reactions.

Recent Company History

Over the past few months, LXRX news has centered on financing and corporate visibility. In late January and early February 2026, the company announced, priced, and closed a public offering and concurrent private placement, with 24-hour moves of -19.44% and -2.44%. Earlier, it proposed the public offering, also followed by a -19.44% move. Neutral items like the upcoming Q4 2025 results release and a Nasdaq closing-bell event saw flat to slightly negative reactions. Today’s conference-participation news fits the non-fundamental, visibility-focused pattern.

Market Pulse Summary

This announcement highlights Lexicon’s engagement with the investment community through multiple Mar...

Analysis

This announcement highlights Lexicon’s engagement with the investment community through multiple March healthcare conferences, including a Leerink fireside chat on March 11 and 1x1 meetings at Jefferies and Barclays events. In recent months, the company has also executed sizeable equity offerings and marked its 30th anniversary. Investors may watch upcoming March 5 earnings and future financing or clinical updates as more material catalysts.

AI-generated analysis. Not financial advice.

THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, at 10:00 a.m.

Lexicon will also be participating in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit, March 10–11, and at the Barclays 28th Global Healthcare Conference, March 10-12.

A live recording and replay of the Leerink fireside chat can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals     
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.

For Investor and Media Inquiries: 
Lisa DeFrancesco  
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com 

FAQ

When is Lexicon Pharmaceuticals (LXRX) scheduled to speak at the Leerink Partners Global Healthcare Conference?

Lexicon will speak at the Leerink fireside chat on March 11, 2026 at 10:00 a.m.. According to the company, a live recording and replay will be posted on the company Events page for later viewing.

Which investor conferences will Lexicon Pharmaceuticals (LXRX) attend in March 2026?

Lexicon will attend Leerink Partners, Jefferies Biotech on the Beach, and Barclays Global Healthcare in March 2026. According to the company, management will hold a Leerink fireside chat and 1x1 investor meetings across those March 10–12 dates.

How can investors watch the Lexicon (LXRX) Leerink fireside chat if they cannot attend on March 11, 2026?

Investors can access a live recording and replay via the company Events page. According to the company, the recording and replay will be posted on the Events page for on-demand viewing after the March 11 session.

Will Lexicon Pharmaceuticals (LXRX) hold one-on-one investor meetings at the March 2026 conferences?

Yes. Lexicon will hold 1x1 investor meetings at Jefferies Biotech on the Beach and at the Barclays Global Healthcare Conference. According to the company, those meetings are scheduled during the March 10–12 conference windows.

Where can investors find details and replays of Lexicon Pharmaceuticals (LXRX) investor presentations in March 2026?

Event details and replay access are available on the company Events page. According to the company, the Leerink fireside chat recording and replay will be posted there for investors to view.